246 related articles for article (PubMed ID: 3389345)
1. Platelet crossmatching. A direct approach to the selection of platelet transfusions for the alloimmunized thrombocytopenic patient.
Kickler TS; Ness PM; Braine HG
Am J Clin Pathol; 1988 Jul; 90(1):69-72. PubMed ID: 3389345
[TBL] [Abstract][Full Text] [Related]
2. A cost-effectiveness evaluation of platelet crossmatching and HLA matching in the management of alloimmunized thrombocytopenic patients.
Freedman J; Gafni A; Garvey MB; Blanchette V
Transfusion; 1989; 29(3):201-7. PubMed ID: 2493693
[TBL] [Abstract][Full Text] [Related]
3. Platelet transfusion therapy in an alloimmunized patient. The value of crossmatch procedures for donor selection.
Hecht T; Wolf JL; Mraz L; Scott EP; Patz LD
JAMA; 1982 Nov; 248(18):2301-3. PubMed ID: 6752444
[TBL] [Abstract][Full Text] [Related]
4. A flow cytometric platelet immunofluorescence crossmatch for predicting successful HLA matched platelet transfusions.
Sintnicolaas K; Löwenberg B
Br J Haematol; 1996 Mar; 92(4):1005-10. PubMed ID: 8616059
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients.
Heal JM; Blumberg N; Masel D
Blood; 1987 Jul; 70(1):23-30. PubMed ID: 3474041
[TBL] [Abstract][Full Text] [Related]
6. Platelet crossmatch testing for donor selection.
Slichter SJ
Prog Clin Biol Res; 1982; 88():153-64. PubMed ID: 7100207
[TBL] [Abstract][Full Text] [Related]
7. Successful transfusion of platelets "mismatched" for HLA antigens to alloimmunized thrombocytopenic patients.
Duquesnoy RJ; Filip DJ; Rodey GE; Rimm AA; Aster RH
Am J Hematol; 1977; 2(3):219-26. PubMed ID: 596366
[TBL] [Abstract][Full Text] [Related]
8. [An evaluation of platelet transfusion response using HLA crossmatch-compatible donors in patients with platelet refractoriness].
Hyun J; Lim YM; Park KD; Han BY; Kim YH; Han KS; Park MH
Korean J Lab Med; 2009 Oct; 29(5):481-9. PubMed ID: 19893359
[TBL] [Abstract][Full Text] [Related]
9. Independent roles for platelet crossmatching and HLA in the selection of platelets for alloimmunized patients.
Friedberg RC; Donnelly SF; Mintz PD
Transfusion; 1994 Mar; 34(3):215-20. PubMed ID: 8146893
[TBL] [Abstract][Full Text] [Related]
10. The predictive value of crossmatching platelet transfusion for alloimmunized patients.
Kickler TS; Braine H; Ness PM
Transfusion; 1985; 25(4):385-9. PubMed ID: 4024239
[TBL] [Abstract][Full Text] [Related]
11. Successful management of alloimmunized patients by transfusing HLA compatible and crossmatched platelets.
Yung CH; Chow MP; Hu HY; Tzeng JL; Mou LL; Deng JM
Zhonghua Yi Xue Za Zhi (Taipei); 1991 Apr; 47(4):228-36. PubMed ID: 1646671
[TBL] [Abstract][Full Text] [Related]
12. Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity.
Petz LD; Garratty G; Calhoun L; Clark BD; Terasaki PI; Gresens C; Gornbein JA; Landaw EM; Smith R; Cecka JM
Transfusion; 2000 Dec; 40(12):1446-56. PubMed ID: 11134563
[TBL] [Abstract][Full Text] [Related]
13. A cross-matching procedure for the selection of platelet donors for alloimmunized patients.
Waters AH; Minchinton RM; Bell R; Ford JM; Lister TA
Br J Haematol; 1981 May; 48(1):59-68. PubMed ID: 7018556
[TBL] [Abstract][Full Text] [Related]
14. Crossmatch-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets.
Gelb AB; Leavitt AD
Transfusion; 1997 Jun; 37(6):624-30. PubMed ID: 9191823
[TBL] [Abstract][Full Text] [Related]
15. Prediction of crossmatch outcome in highly sensitized dialysis patients based on the identification of serum HLA antibodies.
Oldfather JW; Anderson CB; Phelan DL; Cross DE; Luger AM; Rodey GE
Transplantation; 1986 Sep; 42(3):267-70. PubMed ID: 3529527
[TBL] [Abstract][Full Text] [Related]
16. An alloimmunized, thrombocytopenic patient successfully transfused with acid-treated, random-donor platelets.
Shanwell A; Sallander S; Olsson I; Gulliksson H; Pedajas I; Lerner R
Br J Haematol; 1991 Nov; 79(3):462-5. PubMed ID: 1751374
[TBL] [Abstract][Full Text] [Related]
17. Determination of an appropriate size of unrelated donor pool to be registered for HLA-matched platelet transfusion.
Takahashi K; Juji T; Miyazaki H
Transfusion; 1987; 27(5):394-8. PubMed ID: 3477043
[TBL] [Abstract][Full Text] [Related]
18. [Establish a Graded Method to Avoid HLA Class I Antibodies Corresponding Antigen and Combining HLAMatchmaker Application in Improving the CCI Value after Platelet Transfusion for Patients with IPTR].
Gao SQ; Xu YP; Luo CR; Li DC; Pen L; Liu T; Zou QC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):242-249. PubMed ID: 38387929
[TBL] [Abstract][Full Text] [Related]
19. Donor selection for alloimmunized patients by platelet crossmatching of random-donor platelet concentrates.
O'Connell BA; Schiffer CA
Transfusion; 1990 May; 30(4):314-7. PubMed ID: 2349631
[TBL] [Abstract][Full Text] [Related]
20. Selection of platelets for refractory patients by HLA matching and prospective crossmatching.
Moroff G; Garratty G; Heal JM; MacPherson BR; Stroncek D; Huang ST; Ho W; Petz LD; Leach MF; Lennon SS
Transfusion; 1992 Sep; 32(7):633-40. PubMed ID: 1519326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
